Sarah E. Hlavinka - Jan 2, 2024 Form 4 Insider Report for Quanterix Corp (QTRX)

Role
Director
Signature
/s/ Brian Keane, as Attorney-in-Fact
Stock symbol
QTRX
Transactions as of
Jan 2, 2024
Transactions value $
$14,987
Form type
4
Date filed
1/4/2024, 04:09 PM
Previous filing
Oct 4, 2023
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QTRX Common Stock Award $0 +2.95K +7.46% $0.00 42.4K Jan 2, 2024 Direct F1, F2
transaction QTRX Common Stock Award $15K +552 +1.3% $27.15 43K Jan 2, 2024 Direct F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QTRX Stock Option (Right to Buy) Award $0 +6.41K $0.00 6.41K Jan 2, 2024 Common Stock 6.41K $27.15 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest as to 100% of the shares on December 31, 2024 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
F2 Includes 2,947 restricted stock units.
F3 Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2023.
F4 Closing price of the Company's common stock on the Nasdaq Global Market on January 2, 2024.
F5 Represents non-qualified stock option to purchase 6,412 shares of common stock granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy.